This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clanton, D J Articles by Shih, T Y Search for Related Content PubMed PubMed Citation Articles by Clanton, D J Articles by Shih, T Y

Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.

Laboratory of Molecular Oncology, National Cancer Institute, Frederick, Maryland 21701.

ABSTRACT

Point mutations of p21 proteins were constructed by oligonucleotide-directed mutagenesis of the v-rasH oncogene, which substituted amino acid residues within the nucleotide-binding consensus sequence, GXG GXGK. When the glycine residue at position 10, 13, or 15 was substituted with valine, the viral rasH product p21 lost its GTP-binding and autokinase activities. Other substitutions at position 33, 51, or 59 did not impair its binding activity. G418-resistant NIH 3T3 cell lines were derived by transfection with constructs obtained by inserting the mutant proviral DNA into the pSV2neo plasmid. Clones with a valine mutation at position 13 or 15 were incapable of transforming cells, while all other mutants with GTP-binding activity were competent. A mutant with a substitution of valine for glycine at position 10 which had lost its ability to bind GTP and its autokinase activity was fully capable of transforming NIH 3T3 cells. These cells grew in soft agar and rapidly formed tumors in nude mice. The p21 of cell lines derived from tumor explants still lacked the autokinase activity. These findings suggest that the glycine-rich consensus sequence is important in controlling p21 activities and that certain mutations may confer to p21 its active conformation without participation of ligand binding.

This article has been cited by other articles:

• Lillie, S.H., Brown, S.S. (1998). Smy1p, a Kinesin-related Protein That Does Not Require Microtubules. J. Cell Biol. 140: 873-883 [Abstract] [Full Text]  
• Diaz, J. F., Sillen, A., Engelborghs, Y. (1997). Equilibrium and Kinetic Study of the Conformational Transition toward the Active State of p21Ha-ras, Induced by the Binding of BeF3- to the GDP-bound State, in the Absence of GTPase-activating Proteins. J. Biol. Chem. 272: 23138-23143 [Abstract] [Full Text]  
• Becker, K. D., Gottshall, K. R., Hickey, R., Perriard, J.-C., Chien, K. R. (1997). Point Mutations in Human beta  Cardiac Myosin Heavy Chain Have Differential Effects on Sarcomeric Structure and Assembly: An ATP Binding Site Change Disrupts Both Thick and Thin Filaments, Whereas Hypertrophic Cardiomyopathy Mutations Display Normal Assembly. J. Cell Biol. 137: 131-140 [Abstract] [Full Text]  
• Grugel, S., Finkenzeller, Gün., Weindel, K., Barleon, B., Marmé, D. (1995). Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells. J. Biol. Chem. 270: 25915-25919 [Abstract] [Full Text]  
• Bruder, J T, Heidecker, G, Rapp, U R (1992). Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.. Genes Dev. 6: 545-556 [Abstract]  
• Smith, M., Liu, Y., Kim, H, Rhee, S., Kung, H. (1990). Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C. Science 247: 1074-1077 [Abstract]